Huntington National Bank’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4295 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4260 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4224 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4254 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4285 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4256 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4244 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4175 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4039 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3981 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3927 |
|
|
2023
Q2 | $0 | Buy |
+1
| New | +$3 | ﹤0.01% | 3839 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3676 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3594 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2476 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2487 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2424 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2359 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2100 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1991 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1883 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1857 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1806 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1814 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1905 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1927 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1829 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1864 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1855 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1921 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1925 |
|
Huntington National Bank's NBSE Position: Q1 2026 in Review
Huntington National Bank held its NeuBase Therapeutics, Inc. Common Stock (NBSE) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4295.
Huntington National Bank first reported a position in NBSE in Q2 2023 and has held it in 12 quarters since. 1 fund tracked by Wall St. Rank holds NBSE as of Q1 2026.
- Huntington National Bank held 1 share of NeuBase Therapeutics, Inc. Common Stock worth $0 as of Q1 2026.
- Huntington National Bank left its NeuBase Therapeutics, Inc. Common Stock share count unchanged in Q1 2026.
- NeuBase Therapeutics, Inc. Common Stock made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4295 holding.
- Huntington National Bank first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2023 and has held it in 12 quarters since.
- 1 fund tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.